Atopic Dermatitis

Experts discuss pediatric atopic dermatitis treatments
July 24, 2020

Gain insight from the experts on current and future treatment for pediatric atopic dermatitis.

FDA accepts BLA for tralokinumab for atopic dermatitis
July 09, 2020

The U.S. Food and Drug administration has accepted the Biologics License Application for tralokinumab (LEO Pharma) for moderate-to-severe atopic dermatitis and is expected to make a decision in the second quarter of 2021.

Dupilumab, cyclosporine outperform older systemics for atopic dermatitis
July 03, 2020

Researchers of a recent systematic review and meta-analysis examine how dupilumab compares to older systemic treatments for atopic dermatitis, including methotrexate, cyclosporine and azathioprine.